MENU
+Compare
NYXH
Stock ticker: NASDAQ
AS OF
Sep 26 closing price
Price
$4.51
Change
+$0.02 (+0.45%)
Capitalization
168.57M

NYXH Nyxoah SA Forecast, Technical & Fundamental Analysis

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions... Show more

NYXH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NYXH with price predictions
Sep 26, 2025

NYXH's RSI Oscillator stays in oversold zone for 2 days

It is expected that a price bounce should occur soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 20 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NYXH advanced for three days, in of 164 cases, the price rose further within the following month. The odds of a continued upward trend are .

NYXH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 02, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on NYXH as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NYXH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NYXH entered a downward trend on September 26, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.965) is normal, around the industry mean (10.799). P/E Ratio (0.000) is within average values for comparable stocks, (55.315). NYXH's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.704). NYXH has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (28.490) is also within normal values, averaging (14.127).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NYXH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NYXH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
NYXH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NYXH is expected to report earnings to rise 6.02% to -68 cents per share on November 13

Nyxoah SA NYXH Stock Earnings Reports
Q3'25
Est.
$-0.68
Q2'25
Est.
$-0.65
Q1'25
Missed
by $0.16
Q4'24
Est.
$-0.50
Q3'24
Missed
by $0.04
The last earnings report on August 18 showed earnings per share of -64 cents, beating the estimate of -64 cents. With 115.69K shares outstanding, the current market capitalization sits at 168.57M.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
Rue Edouard Belin 12
Phone
+32 10222355
Employees
147
Web
https://www.nyxoah.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KSKGF2.450.15
+6.74%
Kingsgate Consolidated Ltd.
MRMD0.14N/A
+2.14%
MariMed Inc.
TTNDF11.56N/A
N/A
Techtronic Industries Ltd.
ROYL0.04N/A
-1.74%
Royale Energy, Inc.
GIVSY19.72-3.93
-16.63%
Grupo De Inversiones Suramericana S.A.

NYXH and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NYXH has been loosely correlated with LFTSF. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if NYXH jumps, then LFTSF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NYXH
1D Price
Change %
NYXH100%
+0.45%
LFTSF - NYXH
33%
Loosely correlated
N/A
PROF - NYXH
25%
Poorly correlated
+1.95%
NMTC - NYXH
24%
Poorly correlated
+2.22%
TMO - NYXH
23%
Poorly correlated
+1.09%
TDVXF - NYXH
22%
Poorly correlated
+2.08%
More

Groups containing NYXH

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NYXH
1D Price
Change %
NYXH100%
+0.45%
Pharmaceuticals
category (388 stocks)
15%
Poorly correlated
+0.34%
Pharmaceuticals: Other
category (103 stocks)
12%
Poorly correlated
+0.88%